Company Overview and News

 
TIER / Tier Reit Inc. 8-K (Current Report)

2018-09-19 sec.gov
UNITED STATES
TIER

 
TIER REIT, Inc. (TIER) CEO Scott Fordham on Q2 2018 Results - Earnings Call Transcript

2018-08-11 seekingalpha
Greetings, and welcome to the TIER REIT Second Quarter 2018 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded.
TIER

9
TIER REIT Is Priced For Perfection

2018-08-10 seekingalpha
Much of TIER's FFO is eaten up by Tenant improvement costs, leasing commissions, capex, and free rent.
WFC WFCNP FB GOOG TIER GOOGL

 
TIER / Tier Reit Inc. 424B5 (Prospectus)

2018-08-08 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS Prospectus Supplement TABLE OF CONTENTS
TIER

 
TIER / Tier Reit Inc. 8-K (Current Report)

2018-08-08 sec.gov
UNITED STATES<
TIER

1
Tier Reit (TIER) Q2 Earnings and Revenues Top Estimates

2018-08-08 zacks
Tier Reit (TIER - Free Report) just came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.
KRO TIER CIVI SBOW

 
TIER / Tier Reit Inc. 10-Q (Quarterly Report)

2018-08-08 sec.gov
Document UNITED STATES
TIER

 
206
Headwinds Could Be Coming For This Lone Star REIT

2018-06-26 seekingalpha - 1
Tier REIT is a commercial office REIT focused on high growth metros that are becoming increasingly favored by the millennial work force.
BAC FB AMZN CPT TIER

3
Office REITs: Time To Focus On Secondary Markets

2018-06-24 seekingalpha - 1
It would be a good idea to shift the allocation in your portfolio from Class A Primary markets to Secondary markets and both Class A and Class B properties.
CUZ TIER JLL

 
TIER / Tier Reit Inc. 8-K (Current Report)

2018-06-20 sec.gov
Document UNITED STATES
TIER

130
Zacks Investment Ideas feature highlights: Expedia Group, TripAdvisor and Booking Holdings

2018-06-08 zacks
Chicago, IL – June 8, 2018 – Today, Zacks Investment Ideas feature highlights Features: Expedia Group Inc (EXPE - Free Report) , TripAdvisor Inc (TRIP - Free Report) and Booking Holdings (BKNG - Free Report) .
TTWO FIX TRIP LB EXPE BKNG UFPI TIER MU PATK PCLN PETS IO

44
The Zacks Analyst Blog Highlights: Aptiv, Spirax-Sarco Engineering, NMC Health, Safestore Holdings and TT Electronics

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Aptiv PLC (APTV - Free Report) , Spirax-Sarco Engineering plc (SPXSF - Free Report) , NMC Health Plc (NMHLY - Free Report) , Safestore Holdings plc (SFSHF - Free Report) and TT Electronics plc (TTGPF - Free Report) .
SFSHF TTG NMC ALGN BURL NMHLY FIX UFPI SPX TTGPF TIER PATK LULU PETS IO APTV

48
Zacks Industry Outlook Highlights: Alibaba, Amazon, Walmart and Google

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Today, Zacks Equity Research discusses the Industry: E-commerce, including Alibaba (BABA - Free Report) , Amazon (AMZN - Free Report) , Walmart (WMT - Free Report) and Google (GOOGL - Free Report) .
ALGN UFPI BURL GOOGL TIER FIX PATK LULU PETS IO

53
The Zacks Analyst Blog Highlights: Medifast, Chefs' Warehouse and Conagra Brands

2018-06-07 zacks
Chicago, IL – June 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Medifast, Inc. (MED - Free Report) , The Chefs' Warehouse, Inc. (CHEF - Free Report) and Conagra Brands, Inc. (CAG - Free Report) .
ALGN GIS BURL FIX MDLZ CHEF UFPI TIER PATK MED LULU PETS IO

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TIER / Tier Reit Inc. on message board site Silicon Investor.

Research Frontiers (REFR) Research Frontiers (REFR) Research Frontiers (REFR) Gold and Silver Juniors, Mid-tiers and Producers Gold and Silver Juniors, Mid-tiers and Producers Gold and Silver Juniors, Mid-tiers and Producers
Research Frontiers Lonely Hearts Club Thread. Research Frontiers Lonely Hearts Club Thread. Research Frontiers Lonely Hearts Club Thread. Research Frontiers, Inc. REFR Updates Research Frontiers, Inc. REFR Updates Research Frontiers, Inc. REFR Updates
SPACE THE FINAL FRONTIER SPACE THE FINAL FRONTIER SPACE THE FINAL FRONTIER Africa - The Wireless Frontier Africa - The Wireless Frontier Africa - The Wireless Frontier
REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc Gran Tierra Energy (GTE) Gran Tierra Energy (GTE) Gran Tierra Energy (GTE)
The Final Frontier - Online Remote Trading The Final Frontier - Online Remote Trading The Final Frontier - Online Remote Trading LAST FRONTIER OIL CO. LAST FRONTIER OIL CO. LAST FRONTIER OIL CO.
CUSIP: 88650V208